Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2012 · 27 citations · 28 references
Life SciencesImmunologyNeurologyAutoimmunityImmunopathologyNeuroimmunologyAutoimmune Neurological DisordersCerebrospinal Fluid ImmunologyDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisNeuroinflammationCerebrospinal Fluid CytokinesCorrelationDisease Activity MeasurementHumoral Immune DysfunctionHumoral Immunity ImpairmentInflammatory DemyelinationMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis Immunopathology
BACKGROUND: Neuromyelitis optica (NMO) and multiple sclerosis (MS) are inflammatory demyelinating diseases of human central nervous system (CNS) with complex pathogenesis. IL-21/IL-21R regulates activation, proliferation and survival of both T cells and B cells, which are involved in the pathogenesis of NMO and MS. High levels of serum IL-21 were observed in NMO patients. However, concentration of cerebrospinal fluid (CSF) IL-21 in MS and NMO patients still remain unknown. OBJECT: To detect the CSF concentration of IL-21 in NMO and MS patients and to evaluate its relationship with disease activity, particularly concerned about its impact on humoral immunity. METHODS: CSF IL-21 was detected by an enzyme-linked immunosorbent assay (ELISA) in NMO patients (n=21), MS patients (n=20) and controls (n=16). RESULTS: CSF concentration of the IL-21 was noticeably elevated in NMO (p=0.012) and borderline significantly increased in MS (p=0.115). In addition, this occurrence was associated with humoral immune activity as shown by a correlation between IL-21 and complement in NMO cohort (p=0.023) and high IL-21 levels in autoantibody-positive subgroup (p=0.027). CONCLUSIONS: The concentration of CSF IL-21 was noticeably elevated and might have a positive correlation with humoral immune activity in NMO.
28
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text
Medicine, Neurology, Neuroscience +10
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Vanda A. Lennon, Dean M. Wingerchuk, Thomas J. Kryzer et al. · The Lancet · 2004 · 3.2K citations
Life Sciences, Immunology, Neurology +14
Revised diagnostic criteria for neuromyelitis optica
Dean M. Wingerchuk, Vanda A. Lennon, Sean J. Pittock et al. · Neurology · 2006 · 2.6K citations · Full text
Medicine, Neurology, Neuropathology +10
An open label study of the effects of rituximab in neuromyelitis optica
Bruce Cree, Sara Lamb, Katherine A. Morgan et al. · Neurology · 2005 · 646 citations
Medicine, Neurology, Pharmacotherapy +10